George Medicines Logo.JPG
George Medicines appoints Stefan König as Chief Executive Officer
03 juin 2021 07h00 HE | George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...
gmi logo.jpg
2-Phenylethanol Market to hit $350 million by 2027, Says Global Market Insights Inc.
03 juin 2021 06h00 HE | Global Market Insights, Inc
Selbyville, Delaware, June 03, 2021 (GLOBE NEWSWIRE) -- The 2-Phenylethanol Market is projected to cross USD 350 million by 2027, according to a new research report by Global Market Insights Inc....
George Medicines Logo.JPG
George Medicines appoints Stefan König as Chief Executive Officer
03 juin 2021 02h00 HE | George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings
02 juin 2021 07h00 HE | Recro Pharma, Inc.
GAINESVILLE, Ga., June 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
logo.jpg.jpg
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
02 juin 2021 05h00 HE | ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...
cognos.jpg
Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
01 juin 2021 15h49 HE | Cognos Therapeutics Corp.
INGLEWOOD, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Cognos Therapeutics Corp. (“Cognos”, the Company”), an advanced medical device company focused on creating unique...
Onconova Logo BLUE.jpg
Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer
01 juin 2021 08h00 HE | Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 01, 2021 (GLOBE NEWSWIRE) --  Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
QMI-Logo-Long-1000px.jpg
Global Cannabidiol (CBD) Market Size to Grow at a CAGR of 51% from 2021 to 2030
01 juin 2021 06h30 HE | Quince Market Insights
Pune, India, June 01, 2021 (GLOBE NEWSWIRE) -- The global cannabidiol (CBD) market has been estimated to reach USD 2,740 million in 2021 and is projected to grow at a CAGR of around 51% during the...
insightSLICE.png
Surgical Microscopes Market is Expected to Witness Healthy Growth to Reach US$ 2.95 billion Globally by 2031
31 mai 2021 12h30 HE | insightSLICE
PUNE, India, May 31, 2021 (GLOBE NEWSWIRE) -- The Global Surgical Microscopes Market Share, Trends, Analysis and Forecasts, 2021-2031 provides insights on key developments, business strategies,...
logo.jpg
Sanofi: Information concerning the total number of voting rights and shares - April 2021
31 mai 2021 12h00 HE | Sanofi
     Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the...